H.R. 2821 · 119TH CONGRESSHouse · May 21, 2026
FDA Modernization Act 3.0
Take Action
Introduced
House
Senate
Resolving Differences
President
Became Law
Description
FDA Modernization Act 3.0
Summary
No summary available yet.
FDA Modernization Act 3.0
No summary available yet.
Jul 9, 2025 · 14:15
No additional details are available for this hearing yet.
Jul 16, 2025 · 10:00
| Name | Position | Links |
|---|---|---|
| Dr. Candice ChenU.S. Health Resources and Services Administration | Acting Associate Administrator for Health Workforce | |
| Dr. Jacqueline Corrigan-CurayU.S. Food and Drug Administration | Acting Director for Center for Drug Evaluation and Research (CDER) | |
| Mr. Tom MorrisU.S. Health Resources and Services Administration | Associate Administrator for Rural Health Policy |
Referred to the Subcommittee on Health.
Apr 10, 2026
Subcommittee Consideration and Mark-up Session Held
May 13, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026
May 13, 2026 · 14:00
Committee Consideration and Mark-up Session Held
May 21, 2026
Ordered to be Reported by the Yeas and Nays: 44 - 0.
May 21, 2026
May 21, 2026 · 10:00